Category Archives: Press Releases

Global Specimen Solutions, Inc. Releases LabCODE™, a GlobalCODE® Ready, State-of-the-Art, Innovative LIMS System

Raleigh, North Carolina. – September 12, 2017, Global Specimen Solutions, Inc. has announced the release of their latest product LabCODE™, a novel Lab Information Management System (LIMS) built for modern laboratory workflows and storage requirements. LabCODE™ offers pre-built capabilities for Biobanking, Pharmacokinetics, Pharmacogenetics, Next Generation Sequencing, Flow Cytometry, Pathology, and much more. LabCODE™ is fully GlobalCODE® ready and can use the predictive analytics of GlobalCODE® to feed the laboratory workflows, then send full data chain-of-custody back to the powerful GlobalCODE® analytic machine.

“We are very excited to bring another innovative solution to the market for our clients to extend their specimen tracking into the laboratory and biobank. The novel LIMS architecture and approach used to build LabCODE™ is another game-changing technological advancement for specimen management. LabCODE™ is fully integrated with the unmatched capabilities of GlobalCODE®, our premier pipeline data management tool, which has revolutionized live specimen tracking, compliance management, and assay result analytics. With the release of LabCODE™, GlobalCODE® now offers a single solution for clinical trial scientists and laboratory scientists to manage and use powerful integrated data generated internally and externally.”–Amelia Wall Warner, Founder and CEO

Read the Full Press Release Here

Global Specimen Solutions, Inc. Hires Gabriel Balint as Senior Vice President of Software Development

Raleigh, North Carolina. – June 1, 2017, Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), is pleased to announce the addition of Gabriel Balint as Senior Vice President of Software Development as it grows the leadership team for Software Product development.

“Global Specimen Solutions, Inc. is very excited to have Gabriel join our Senior Leadership team. Gabriel has extensive experience in the Specimen Management Software market and has become known for his innovative, disruptive approach to automation. This is a perfect fit for our business approach in creating fit-for-purpose, new market approaches for specimen based research.”–Amelia Wall Warner, Founder and CEO

Read the Full Press Release Here

Global Specimen Solutions, Inc. Expands, Receives Two Triangle Business Journal Awards for 2017, Including the Triangle’s Best CRO

Global Specimen Solutions, Inc. (http://www.globalspecimensolutions.com), was selected by the Triangle Business Journal (TBJ) for 2017 Best CRO for the Life Science Awards and Women in Business, Entrepreneur winner for the CEO, Amelia Wall Warner.

“Global Specimen Solutions, Inc. is thrilled to be recognized for the hard work and innovative market solutions developed by our talented team. Our company is growing rapidly and having this recognition is thrilling for all of us.” –Amelia Wall Warner, Founder and CEO’

Read the Full Press Release Here

Global Specimen Solutions, Inc. Announces 5-Year Strategic Alliance with Covance

RALEIGH, NC (PRWEB) OCTOBER 13, 2016

Global Specimen Solutions (GSS) today announced a five-year strategic alliance with Covance, the drug development business of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH). Covance’s market-leading central laboratory will offer GSS products GlobalCODE® and snapTRACK™ to its pharmaceutical and biotechnology clients to provide streamlined global specimen tracking, as well as informed consent and assay result management that will deliver actionable insights from specimens across development programs. Covance will be the exclusive lab to offer GSS’s services for pharmaceutical development.

Read the Full Press Release Here

Advanced Precision Medicine, Inc. engages Global Specimen Solutions, Inc. to identify molecular diagnostics for commercial launch in U.S. CLIA labs

Advanced Precision Medicine, Inc. (APM), a commercialization catalyst for molecular diagnostics, today announced that it has engaged the services of a specialty specimen management clinical research organization, Global Specimen Solutions, Inc. (GSS), to qualify innovative molecular diagnostics for inclusion in the Syner-G portfolio of molecular diagnostics. APM’s Syner-G portfolio of molecular diagnostics includes applications in oncology, autoimmunity, wellness, and pain management.

Read Advanced Precision Medicine, Inc.’s Press Release Here

Continue reading Advanced Precision Medicine, Inc. engages Global Specimen Solutions, Inc. to identify molecular diagnostics for commercial launch in U.S. CLIA labs

Global Specimen Solutions, Inc. Expands, Moving Corporate Offices to North Raleigh

Media Contact:
L. Scott Clark, Ph.D.
VP, Global Quality Assurance
Global Specimen Solutions
919.741.5008 x 115
scott.clark@globalspecimensolutions.com

High Growth Trajectory for the Specialist CRO Leads to New Offices in a Prime Location

August 4, 2015

Raleigh, North Carolina. – August 1, 2015, Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), moved its offices to North Raleigh, expanding its footprint to allow for continued rapid growth of the company.

“Global Specimen Solutions, Inc. is growing at a rapid pace, providing innovative solutions that reduce the time, cost, and risk of specimen-based research.  Our solutions have been in demand in the market, requiring us to accelerate our corporate growth plan.  By locating in North Raleigh in the center of high growth biopharma companies, Global Specimen Solutions, Inc. is well positioned for its next phase of growth.” –Amelia Wall Warner, Founder and CEO

Global Specimen Solutions, Inc. located its offices in the Raleigh-Durham-Chapel Hill area to capitalize on the dynamic community of universities, informatics, and biopharma companies.  Selecting a prime location was a key to assuring visibility and accessibility of the company to its client base.

“Global Specimen Solutions, Inc. continues to benefit from the rich scientific community in this area, drawing expertise for collaboration and partnerships as well as recruiting from a highly qualified local talent pool.”- Amelia Wall Warner, Founder and CEO

Continue reading Global Specimen Solutions, Inc. Expands, Moving Corporate Offices to North Raleigh

Global Specimen Solutions Selected by Volition RX to Support Initial U.S. Market Entry of its NuQ® Colorectal Cancer Tests

GSS is very excited to work with Volition Rx on this very promising technology by assisting Volition RX in their identification and collaborations with select medical universities and CLIA labs in the U.S.

Read Volition RX’s Press Release Here

Continue reading Global Specimen Solutions Selected by Volition RX to Support Initial U.S. Market Entry of its NuQ® Colorectal Cancer Tests

Global Specimen Solutions, Inc. Appoints Mark A. Collins Ph.D. as Chief Technology Officer

GSS Builds Informatics Expertise

July 14, 2015
Raleigh, North Carolina. – Global Specimen Solutions, Inc, an innovative specialty CRO focused on specimen management and informatics, announced today that Mark A Collins, PhD has joined the company as Chief Technology Officer.

Dr. Collins brings to Global Specimen Solutions, a unique combination of scientific, technical and business expertise, gained in a 20+ year career in start-ups, biotechnology and pharmaceutical companies, government research labs and as a co-founder of three companies.

Continue reading Global Specimen Solutions, Inc. Appoints Mark A. Collins Ph.D. as Chief Technology Officer

Global Specimen Solutions, Inc. Announces New Board of Directors

GSS Builds Advisory Expertise for New Growth Phase of Company

February 24, 2015
Cary, North Carolina. – Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), an innovative specialty CRO focused on specimen management and informatics, announced today that Allen A Spizzo and Kay Gamble are joining the Board of Directors..

“Global Specimen Solutions, Inc. is excited to have two individuals with strong and diverse  business expertise  joining our Board of Directors to help guide our new growth phase for the company.  Mr. Spizzo brings global business and financial expertise to our Board, and will help guide our  financial development, planning and investment phases for informatics and growth.  Ms. Gamble brings international marketing expertise across chemical and biotechnology sectors to our Board, helping launch our international approaches to Global Specimen Solutions marketing.”  –Amelia Wall Warner, Founder and CEO.

Continue reading Global Specimen Solutions, Inc. Announces New Board of Directors

Global Specimen Solutions, Inc. Closes Series A Funding

GSS Builds Momentum for Specialty Specimen CRO Services and Infrastructure

Cary, North Carolina. – Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), an innovative specialty CRO focused on specimen management and informatics, announced today that Series A funding was closed.

“Global Specimen Solutions, Inc. is excited to catapult our growing momentum in clinical specimen management with investment that will further enhance our proprietary informatics tools and infrastructure to build our first-to-market services supporting specimen research. GSS has proved rapid market uptake of our clinical trial management services and products for translational medicine, and this funding will help speed introduction of new proprietary tools to our growing client base.” –Amelia Wall Warner, Founder and CEO

Continue reading Global Specimen Solutions, Inc. Closes Series A Funding